demonstrated that non-small cell lung cancer patients with higher pre-treatment Mg2+ levels exhibited longer progression-free survival and overall survival when receiving epidermal growth factor receptor TKIs therapy (14). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.